Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Novavax Inc
NVAXCurrent price
7.25 USD
+0.15 USD (+2.11%)
Last closed
7.29 USD
Company
www.novavax.com
ISIN
US6700024010
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
1 180 761 344 USD
Yield for 12 month
-53.27 %
1Y
3Y
5Y
10Y
15Y
NVAX
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland. Address: 700 Quince Orchard Road, Gaithersburg, MD, United States, 20878
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
14.67 USDP/E ratio
2.65Dividend Yield
–Current Year
+682 162 000 USD
Last Year
+556 382 000 USD
Current Quarter
+666 655 000 USD
Last Quarter
+88 311 000 USD
Current Year
+479 423 000 USD
Last Year
+212 614 000 USD
Current Quarter
+652 540 000 USD
Last Quarter
+51 642 000 USD
Key Figures NVAX
1 year
3 years
5 years
10 years
EBITDA
467 502 016 USD
Operating Margin TTM
Price to Earnings
2.65
Return On Assets TTM
19.97 %
PEG Ratio
–
Return On Equity TTM
-898.20 %
Wall Street Target Price
14.67 USD
Revenue TTM
1 254 962 048 USD
Book Value
-0.47 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
610.30 %
Dividend Yield
–
Gross Profit TTM
732 558 016 USD
Earnings per share
2.75 USD
Diluted Eps TTM
2.75 USD
Most Recent Quarter
I 2025
Quarterly Earnings Growth YOY
70.90 %
Profit Margin
38.14 %
Dividend Analytics NVAX
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History NVAX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:20
Payout Ratio TTM
–
Last Split Date
10.05.2019
Stock Valuation NVAX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
2.65
Forward PE
7.86
Enterprise Value Revenue
0.53
Price Sales TTM
0.94
Enterprise Value EBITDA
1.17
Price Book MRQ
49.52
Financials NVAX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NVAX
For 52 weeks
5.01 USD
23.86 USD
50 Day MA
6.74 USD
Shares Short Prior Month
41 028 051
200 Day MA
9.16 USD
Short Ratio
5.73
Shares Short
42 333 778
Short Percent
26.23 %
BeatStart